We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bayer, J&J Look To Bar Amended Master Xarelto Complaint

Law360 (March 7, 2018, 7:44 PM EST) -- A pair of Bayer AG and Johnson & Johnson units have urged a Pennsylvania judge to bar a substantially amended master complaint in a mass tort program over the blood-thinner Xarelto from being filed as they gear up for a set of bellwether trials to begin next month.

Bayer Healthcare Pharmaceuticals Inc. and Janssen Pharmaceuticals Inc. said Monday that allowing a new master complaint, which lays out general allegations in each of the 1,700 Xarelto-related cases pending as part of a mass tort program in Philadelphia...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.